Changchang Jia

Dr. Changchang Jia

Cell-Gene Therapy Translational Medicine Research Center,The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
QYQing Yang
Qing Yang
BXBinhui Xie
Binhui Xie
HTHui Tang
Hui Tang
WMWei Meng
Wei Meng
CJChangchang Jia
Changchang Jia
BFBinsheng Fu
Binsheng Fu
Hepatocellular carcinoma (HCC) is the most common tumors in the worldwide, it develops resistance to radiotherapy during treatment, understanding the regulatory mechanisms of radioresistance generation is the urgent need for HCC therapy. qRT-PCR, western blot and immunohistochemistry were used to examine MCM3 expression. MTT assay, colony formation assay, terminal deoxynucleotidyl transferase nick end labeling assay and In vivo xenograft assay were used to determine the effect of MCM3 on radioresistance. Gene set enrichment analysis, luciferase reporter assay, western blot and qRT-PCR were used to examine the effect of MCM3 on NF-κB pathway. We found DNA replication initiation protein Minichromosome Maintenance 3 (MCM3) was upregulated in HCC tissues and cells, patients with high MCM3 expression had poor outcome, it was an independent prognostic factor for HCC. Cells with high MCM3 expression or MCM3 overexpression increased the radioresistance determined by MTT assay, colony formation assay, TUNEL assay and orthotopic transplantation mouse model, while cells with low MCM3 expression or MCM3 knockdown reduced the radioresistance. Mechanism analysis showed MCM3 activated NF-κB pathway, characterized by increasing the nuclear translocation of p65, the expression of the downstream genes NF-κB pathway and the phosphorylation of IKK-β and IκBα. Inhibition of NF-κB in MCM3 overexpressing cells using small molecular inhibitor reduced the radioresistance, suggesting MCM3 increased radioresistance through activating NF-κB pathway. Moreover, we found MCM3 expression positively correlated with NF-κB pathway in clinic. Our findings revealed that MCM3 promoted radioresistance through activating NF-κB pathway, strengthening the role of MCM subunits in the tumor progression and providing a new target for HCC therapy.

23 April 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
HZHuang Zenan
Huang Zenan
LZLi Zixiong
Li Zixiong
YZYao Zhicheng
Yao Zhicheng
HMHuang Mei
Huang Mei
YXYang Xiongbin
Yang Xiongbin
CJChangchang Jia
Changchang Jia

15 July 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
CJChangchang Jia
Changchang Jia
ZYZhicheng Yao
Zhicheng Yao
ZLZexiao Lin
Zexiao Lin
LZLiyun Zhao
Liyun Zhao
XCXiurong Cai
Xiurong Cai
QZQi Zhang
Qi Zhang

30 July 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
LLLing Li
Ling Li
XLXu Lu
Xu Lu
QLQinghai Lian
Qinghai Lian
XWXiaoyun Wang
Xiaoyun Wang
CJChangchang Jia
Changchang Jia
CXChengfang Xu
Chengfang Xu
Macrophages play a crucial role in the development of early-onset preeclampsia (EOPE), which may be closely associated with an imbalance in macrophage M1/M2 polarization. Mesenchymal stem cell (MSC)-derived apoptotic vesicles (apoVs) have anti-inflammatory, tissue repair, and immunomodulatory functions. MSC-apoVs may ameliorate EOPE by regulating macrophage polarization, but the underlying mechanisms remain to be clarified. Macrophage infiltration and M1/M2 polarization were first analyzed in the placentas of PE patients and normal pregancies to identify macrophage alterations in EOPE placentas. MSC-apoVs were extracted and characterized. The effects of MSC-apoVs on macrophage polarization and trophoblasts invasion were validated in vivo and in vitro. miRNA transcriptomic sequencing of MSC-apoVs was conducted to identify key miRNAs involved in macrophage M2 polarization and to investigate upstream and downstream regulation factors, which were further validated in vivo and in vitro. The proportion of M2 macrophages was significantly reduced in EOPE placentas. MSC-apoVs carrying high levels of miR-191-5p recruited macrophages, downregulated CDK6 protein expression, stabilized mitochondrial membrane potential (MMP), and promoted M2 polarization of macrophages. This enhanced the invasion of trophoblasts and improved EOPE pregnancy outcomes in mice, including reduced blood pressure, decreased urine protein, and improved embryo quality. Overexpression of miR-191-5p mimics in MSC-apoVs further alleviated EOPE-related symptoms, whereas inhibition of miR-191-5p reduced the therapeutic effect of MSC-apoVs. Further experiments confirmed that M2 macrophages polarized by MSC-apoVs promote trophoblasts invasion by secreting platelet-derived growth factor-AB (PDGF-AB), which binds to platelet-derived growth factor receptor-beta (PDGFR-β) on trophoblasts, directly activating the downstream PI3K-AKT-mTOR signaling pathway, thereby improving EOPE. Our findings reveal the crucial role of M2 macrophages in the pathogenesis of EOPE. MSC-apoVs with high miR-191-5p recruit macrophages, downregulate CDK6, stabilize MMP, and promote M2 polarization, increasing PDGF-AB secretion, which enhances trophoblasts invasion and thereby treat EOPE. Therefore, MSC-apoVs therapy may serve as a promising strategy to improve the prognosis of EOPE.

12 September 2024 in Oncogenesis
Verified
Journal Article
Open access
PDF file
DQDongbo Qiu
Dongbo Qiu
TWTiantian Wang
Tiantian Wang
YXYi Xiong
Yi Xiong
KLKun Li
Kun Li
XQXiusheng Qiu
Xiusheng Qiu
CJChangchang Jia
Changchang Jia
Hepatocellular carcinoma (HCC) is a prevalent and aggressive malignancy associated with high risks of recurrence and metastasis. Liver cancer stem cells (CSCs) are increasingly recognized as pivotal drivers of these processes. In our previous research, we demonstrated the involvement of TFCP2L1 in maintaining the pluripotency of embryonic stem cells. However, its relevance to liver CSCs remains unexplored. In this study, we report an inverse correlation between TFCP2L1 protein levels in HCC tissue and patient outcomes. The knockdown of TFCP2L1 significantly reduced HCC cell proliferation, invasion, metastasis, clonal formation, and sphere-forming capacity, while its overexpression enhanced these functions. In addition, experiments using a nude mouse model confirmed TFCP2L1’s essential role in liver CSCs’ function and tumorigenic potential. Mechanistically, we showed that TFCP2L1 promotes the stemness of CSCs by upregulating NANOG, which subsequently activates the JAK/STAT3 pathway, thereby contributing to HCC pathogenesis. Importantly, we identified a specific small molecule targeting TFCP2L1’s active domain, which, in combination with Sorafenib, sensitizes hepatoma cells to treatment. Together, these findings underscore TFCP2L1’s pathological significance in HCC progression, supporting its potential as a prognostic biomarker and therapeutic target in this disease.

14 March 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
YFYuan Feng
Yuan Feng
JLJing Luo
Jing Luo
JCJintao Cheng
Jintao Cheng
AXAimin Xu
Aimin Xu
DQDongbo Qiu
Dongbo Qiu
NLNan Lin
Nan Lin
Mesenchymal stem cells (MSCs) have a variety of unique properties, such as stem cell multipotency and immune regulation, making them attractive for use in cell therapy. Before infusion therapy, MSCs are required to undergo tissue separation, purification, and expansion in vitro for a certain duration. During the process of in vitro expansion of MSCs, the influence of culture time and environment can lead to cell senescence, increased heterogeneity, and function attenuation, which limits their clinical applications. We used a cocktail of three small-molecule compounds, ACY (A-83–01, CHIR99021, and Y-27632), to increase the proliferation activity of MSCs in vitro and reduce cell senescence. ACY inhibited the increase in heterogeneity of MSCs and conserved their differentiation potential. Additionally, ACY maintained the phenotype of MSCs and upregulated the expression of immunomodulatory factors. These results suggest that ACY can effectively improve the quantity and quality of MSCs.